請選擇規(guī)格
¥17058.6
以上報價是含稅價格
規(guī)格
貨號:
規(guī)格
規(guī)格 | 16樣本(產(chǎn)品加服務(wù))、64樣本、32樣本(產(chǎn)品加服務(wù))、64樣本(產(chǎn)品加服務(wù))、16樣本、32樣本 |
樣本類型 | Cell Culture Supernatants, Plasma, Serum, Tissue Lysates, Cell Lysates |
原理方法 | Sandwich-based |
檢測方法 | Fluorescence Laser Scanner |
定量與否 | Semi-Quantitative |
載體 | Glass Slide |
適用種屬 | Mouse |
檢測靶標 | CXCL16, MIP-2, LIX, MCP-5, MIP-1 gamma, Eotaxin-1 / CCL11, MIP-1 alpha / CCL3, RANTES / CCL5, BLC / CXCL13, MIG / CXCL9, CXCL2 / CINC-3 / MIP2, MCP-1 / CCL2, CXCL1 / GRO alpha / KC / CINC-1, MIP-3 alpha / CCL20, 6Ckine / CCL21, CTACK / CCL27, ENA-78 / CXCL5, Eotaxin-2 / MPIF-2 / CCL24, Fractalkine / CX3CL1, I-309 / TCA-3 / CCL1, I-TAC / CXCL11, MDC / CCL22, MIP-3 beta / CCL19, Platelet Factor 4 / CXCL4, SDF-1 alpha / CXCL12 alpha, TARC / CCL17, TECK / CCL25 |
靶標數(shù) | 25 |
詳細描述
Scroll over each target protein for more information | ||||
---|---|---|---|---|
6Ckine (CCL21)
| BLC (CXCL13)
| CTACK (CCL27)
| CXCL16
| Eotaxin-1 (CCL11)
|
Eotaxin-2 (MPIF-2/CCL24)
| Fractalkine (CX3CL1)
| I-309 (TCA-3/CCL1)
| I-TAC (CXCL11)
| KC (CXCL1)
|
LIX
| MCP-1 (CCL2)
| MCP-5
| MDC (CCL22)
| MIG (CXCL9)
|
MIP-1 alpha (CCL3)
| MIP-1 gamma
| MIP-2
| MIP-3 alpha (CCL20)
| MIP-3 beta (CCL19)
|
Platelet Factor 4 (CXCL4)
| RANTES (CCL5)
| SDF-1 alpha (CXCL12 alpha)
| TARC (CCL17)
| TECK (CCL25)
|
相關(guān)產(chǎn)品
Human Immune Checkpoint Receptor Protein Array
CHO Residual DNA Quantification Kit
Uric Acid Assay Kit (Colorimetric)
Total Cholesterol Assay Kit (Colorimetric)
Superoxide Dismutase (SOD) Activity Assay Kit (Colorimetric)
Peroxidase Activity Assay Kit (Colorimetric)
文件
文獻(1)
Downregulation of SEPTIN5 inhibits prostate cancer progression by increasing CD8+ T cell infiltration,Abdelfattah Amira Mohammed, Mahmoud Shireen Sami, EL-wafaey Dalia Ibrahim, Abdelgeleel Heba Mahmoud, Abdelhamid Amira Mohamed,Scientific Reports ,(IF:4.6) | |
Species: | Mouse |
Sample Type: | unknown |
通過郵件收到學術(shù)資源和優(yōu)惠信息
微信公眾號